Kamis, 19 Mei 2011
Breast cancer drug Avastin controversy - breast cancer, new drugs - the pharmaceutical industry
Approve New Drugs Avastin (Avastin) for the treatment of advanced breast cancer. Advanced breast cancer refers to tumor cells have spread to other organs, such as lung, liver, or bone cancer. FDA approval was letting some people be surprised to some extent, let the other person has some expectations, however, FDA decided that an advisory committee in December recommended that the withdrawal of the drug's approval, nor that the opposing views less, the voting result is 5:4.
Langganan:
Posting Komentar (Atom)
Tidak ada komentar:
Posting Komentar